SCHEMBL29176403

SCHEMBL29176403

O=C1CC=CC2=C1OCCO2

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.33
CA9 Q16790 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11425305 0.75
SCHEMBL3520833 0.70
SCHEMBL15903643 0.67
SCHEMBL3497269 0.65
SCHEMBL14335006 0.65 PIK3CA (0.30)
SCHEMBL594794 0.65 CA1 (0.44) CA1CA9
SCHEMBL15561244 0.65 CA1 (0.33) CA1CA9
SCHEMBL29699894 0.64 NTSR1 (0.33)
SCHEMBL18266083 0.63 CA1 (0.32) CA1CA9
SCHEMBL10524686 0.63 CA1 (0.38) CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715647-A Treatment of cancer with NK cells and CD38 targeting antibodies 埃迪瓦生物治疗公司 2024-03-15 CN disclosed
CN-117545490-A Treatment of cancer with NK cells and HER2 targeting antibodies 埃迪瓦生物治疗公司 2024-02-09 CN disclosed